Anaveon
Nicole Egli is a senior scientist at Anaveon, a biotech company that focuses on developing therapies for autoimmune and inflammatory diseases. Nicole previously worked as a scientist at Novartis Institutes for BioMedical Research from April 2010 to September 2020.
Nicole Egli received their Master of Science in Zell-/Zellularbiologie und Molekularbiologie from ETH Zürich.
Their manager is Christoph Huber, Chief Scientific Officer. Some of their coworkers include Laetitia Petersen - Senior Scientist, Pia Neubert - Associate Scientist, and Alexander Rau - Scientist, Protein Engineering.
This person is not in any offices
Anaveon
1 followers
Anaveon is a developing IL-2 complexes which selectively promote effector T cell functions.